Pyrazinamide

Product NDC
70954-484
11-digit product format
709540484
Labeler code
70954
Product ID
70954-484_e043f21d-4a30-4d23-bc03-12207af7d6d7
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Pyrazinamide
Dosage form
TABLET
Route
ORAL
Labeler
ANI Pharmaceuticals, Inc.
Application
ANDA080157
Marketing category
ANDA
Marketing start
2021-05-11
Substance
PYRAZINAMIDE
Active strength
500 mg/1
Pharmacologic classes
Antimycobacterial [EPC]
NDC exclude flag
No
Listing certified through
2027-12-31
Current FDA listing
Yes

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 1 matching rows.

Dataset, Scope, Product NDC table
DatasetScopeProduct NDCPackage NDCCodeStatusReporting periodSource date
excluded packagepackage70954-48470954-484-40DDiscontinued by firm2026-08-17

Source provenance: Browse the complete Orange Book source catalog · source snapshot 42.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
A080157-001PYRAZINAMIDEPYRAZINAMIDE500MGTABLET / ORALABRLD, Approved before 1982

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 1 matching rows.

Application-product, TE code table
Application-productTE code
A080157-001AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 42 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-08-18 06:07:402026-07A080157-001PYRAZINAMIDE500MGTABLET / ORALABRLD, Approved before 1982caaa826d4ba7…
2026-02-19 14:30 UTC2026-02A080157-001PYRAZINAMIDE500MGTABLET / ORALABRLD, Approved before 1982011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A080157-001PYRAZINAMIDE500MGTABLET / ORALABRLD, Approved before 198231067a03dcf5…
2025-08-23 18:47 UTC2025-08A080157-001PYRAZINAMIDE500MGTABLET / ORALABRLD, Approved before 19826a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A080157-001PYRAZINAMIDE500MGTABLET / ORALABRLD, Approved before 1982fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A080157-001PYRAZINAMIDE500MGTABLET / ORALABRLD, Approved before 1982b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A080157-001PYRAZINAMIDE500MGTABLET / ORALABRLD, Approved before 198203ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A080157-001PYRAZINAMIDE500MGTABLET / ORALABRLD, Approved before 19822680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09A080157-001PYRAZINAMIDE500MGTABLET / ORALABRLD, Approved before 19825bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11A080157-001PYRAZINAMIDE500MGTABLET / ORALABRLD, Approved before 1982d8e5a09893c0…
2024-10-29 15:01 UTC2024-10A080157-001PYRAZINAMIDE500MGTABLET / ORALABRLD, Approved before 1982d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08A080157-001PYRAZINAMIDE500MGTABLET / ORALABRLD, Approved before 198279d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07A080157-001PYRAZINAMIDE500MGTABLET / ORALABRLD, Approved before 1982301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06A080157-001PYRAZINAMIDE500MGTABLET / ORALABRLD, Approved before 19821e350fbaab3a…
2024-05-31 18:47 UTC2024-05A080157-001PYRAZINAMIDE500MGTABLET / ORALABRLD, Approved before 19828072bd15b7f6…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06A080157-001PYRAZINAMIDE500MGTABLET / ORALABRLD, Approved before 19825c6f7cd8ea54…
2022-04-08 23:34 UTC2022-04A080157-001PYRAZINAMIDE500MGTABLET / ORALABRLD, Approved before 19825d02ea3f76ae…
2022-04-04 05:41 UTC2022-04A080157-001PYRAZINAMIDE500MGTABLET / ORALABRLD, Approved before 19824b0b4de00fa7…
2019-12-13 00:20 UTC2019-12A080157-001PYRAZINAMIDE500MGTABLET / ORALABRS, Approved before 198274a2ff9319b5…
2022-03-09 01:35 UTC2022-03A080157-001PYRAZINAMIDE500MGTABLET / ORALABRLD, Approved before 1982bb7c543d1eb4…
2021-12-28 21:50 UTC2021-12A080157-001PYRAZINAMIDE500MGTABLET / ORALABRLD, Approved before 1982782e0a99824c…
2021-05-05 16:15 UTC · 3 captures of this ZIP2021-05A080157-001PYRAZINAMIDE500MGTABLET / ORALApproved before 198287673890dc5c…
2021-03-12 10:30 UTC2021-03A080157-001PYRAZINAMIDE500MGTABLET / ORALApproved before 19825aa47cf7b7d7…
2020-12-22 03:56 UTC2020-12A080157-001PYRAZINAMIDE500MGTABLET / ORALApproved before 19828869cabd3fbd…
2020-11-12 02:37 UTC2020-11A080157-001PYRAZINAMIDE500MGTABLET / ORALApproved before 1982c0c555d07b60…
2019-12-14 00:12 UTC2019-12A080157-001PYRAZINAMIDE500MGTABLET / ORALABRS, Approved before 19823f01610625f2…
2019-09-15 20:21 UTC2019-09A080157-001PYRAZINAMIDE500MGTABLET / ORALABRS, Approved before 1982b00525d2431f…
2019-07-19 19:46 UTC2019-07A080157-001PYRAZINAMIDE500MGTABLET / ORALABRS, Approved before 1982ea99ee380514…
2024-03-16 18:09 UTC · 4 captures of this ZIP2024-03A080157-001PYRAZINAMIDE500MGTABLET / ORALABRLD, Approved before 19826a51e52b5d6a…
2024-02-18 07:12 UTC2024-02A080157-001PYRAZINAMIDE500MGTABLET / ORALABRLD, Approved before 19821c564ffb4f44…
2023-12-20 04:57 UTC2023-12A080157-001PYRAZINAMIDE500MGTABLET / ORALABRLD, Approved before 1982ea1830bbd6c7…
2023-11-28 05:40 UTC · 2 captures of this ZIP2023-11A080157-001PYRAZINAMIDE500MGTABLET / ORALABRLD, Approved before 1982a72a2bbeb626…
2023-10-25 00:34 UTC · 2 captures of this ZIP2023-10A080157-001PYRAZINAMIDE500MGTABLET / ORALABRLD, Approved before 19829b2671bbb829…
2023-07-15 15:27 UTC · 2 captures of this ZIP2023-07A080157-001PYRAZINAMIDE500MGTABLET / ORALABRLD, Approved before 1982a67488948f0b…
2023-06-13 01:57 UTC · 3 captures of this ZIP2023-06A080157-001PYRAZINAMIDE500MGTABLET / ORALABRLD, Approved before 19823f0d92c62455…
2023-05-13 08:27 UTC2023-05A080157-001PYRAZINAMIDE500MGTABLET / ORALABRLD, Approved before 1982053a50430f4f…
2023-01-26 05:58 UTC2023-01A080157-001PYRAZINAMIDE500MGTABLET / ORALABRLD, Approved before 19823bdfa0b2c4d7…
2022-11-12 20:34 UTC · 5 captures of this ZIP2022-11A080157-001PYRAZINAMIDE500MGTABLET / ORALABRLD, Approved before 19823a93d1ddd44b…
2022-10-28 04:53 UTC2022-10A080157-001PYRAZINAMIDE500MGTABLET / ORALABRLD, Approved before 1982f41ea6bd6efb…
2022-09-29 23:25 UTC2022-09A080157-001PYRAZINAMIDE500MGTABLET / ORALABRLD, Approved before 1982e64feba35796…

Observed Orange Book normalized TE history#

Captured, Edition, Application-product table
CapturedEditionApplication-productTE codeOrderSource SHA-256
2026-08-18 06:07:402026-07A080157-001AB1caaa826d4ba7…
2026-02-19 14:30 UTC2026-02A080157-001AB1011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A080157-001AB131067a03dcf5…
2025-08-23 18:47 UTC2025-08A080157-001AB16a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A080157-001AB1fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A080157-001AB1b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A080157-001AB103ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A080157-001AB12680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09A080157-001AB15bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11A080157-001AB1d8e5a09893c0…
2024-10-29 15:01 UTC2024-10A080157-001AB1d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08A080157-001AB179d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07A080157-001AB1301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06A080157-001AB11e350fbaab3a…
2024-05-31 18:47 UTC2024-05A080157-001AB18072bd15b7f6…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06A080157-001AB15c6f7cd8ea54…
2022-04-08 23:34 UTC2022-04A080157-001AB15d02ea3f76ae…
2022-04-04 05:41 UTC2022-04A080157-001AB14b0b4de00fa7…
2019-12-13 00:20 UTC2019-12A080157-001AB174a2ff9319b5…
2022-03-09 01:35 UTC2022-03A080157-001AB1bb7c543d1eb4…
2021-12-28 21:50 UTC2021-12A080157-001AB1782e0a99824c…
2019-12-14 00:12 UTC2019-12A080157-001AB13f01610625f2…
2019-09-15 20:21 UTC2019-09A080157-001AB1b00525d2431f…
2019-07-19 19:46 UTC2019-07A080157-001AB1ea99ee380514…
2024-03-16 18:09 UTC · 4 captures of this ZIP2024-03A080157-001AB16a51e52b5d6a…
2024-02-18 07:12 UTC2024-02A080157-001AB11c564ffb4f44…
2023-12-20 04:57 UTC2023-12A080157-001AB1ea1830bbd6c7…
2023-11-28 05:40 UTC · 2 captures of this ZIP2023-11A080157-001AB1a72a2bbeb626…
2023-10-25 00:34 UTC · 2 captures of this ZIP2023-10A080157-001AB19b2671bbb829…
2023-07-15 15:27 UTC · 2 captures of this ZIP2023-07A080157-001AB1a67488948f0b…
2023-06-13 01:57 UTC · 3 captures of this ZIP2023-06A080157-001AB13f0d92c62455…
2023-05-13 08:27 UTC2023-05A080157-001AB1053a50430f4f…
2023-01-26 05:58 UTC2023-01A080157-001AB13bdfa0b2c4d7…
2022-11-12 20:34 UTC · 5 captures of this ZIP2022-11A080157-001AB13a93d1ddd44b…
2022-10-28 04:53 UTC2022-10A080157-001AB1f41ea6bd6efb…
2022-09-29 23:25 UTC2022-09A080157-001AB1e64feba35796…
2022-07-09 03:26 UTC · 3 captures of this ZIP2022-07A080157-001AB1cb3db0bc1861…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06A080157-001AB1a50c72e98297…

Additional Listing Data#

Finished product
Yes
Brand name base
Pyrazinamide
Listing expiration
2027-12-31

Active Ingredients#

Ingredient, Strength table
IngredientStrength
PYRAZINAMIDE500 mg/1

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
2KNI5N06TIInternal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
198181Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
262d8829-728c-48db-b89b-88d13b87e684Available on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
74627275-f344-a42f-8f8b-d6190f614e0eProduct name220210211
7cf7f62d-3767-728f-c117-96e96c1ed8bfProduct name120140508

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
70954-484-10Pyrazinamide60 in 1 BOTTLETABLET602
70954-484-20Pyrazinamide90 in 1 BOTTLETABLET902
70954-484-30Pyrazinamide100 in 1 BOTTLETABLET1002
70954-484-40Pyrazinamide500 in 1 BOTTLETABLET5002

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
70954-484-10EA - Each70954-4845aca53e7-6b0c-4841-adfc-a9f1b5a37e6012021-08-05
70954-484-20EA - Each70954-484cc040fd8-bd5e-47ac-bff1-a396a786fc6712021-08-05
70954-484-30EA - Each70954-484a829b817-b002-46e6-bfdf-039e5df91e4e12021-08-05
70954-484-40EA - Each70954-48472741e30-9761-48f6-89ae-dfe90b1a3f9f12021-08-05

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
70954-484PYRAZINAMIDE TABLET [NOVITIUM PHARMA LLC]1Current NDC, Legacy NDC, 4 package rows20210514_262d8829-728c-48db-b89b-88d13b87e684.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 3 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
PyrazinamidePYRAZINAMIDEANI Pharmaceuticals, Inc.262d8829-728c-48db-b89b-88d13b87e6842026-03-02Warnings, Adverse reactionsExact identifier
application applno (ANDA): 080157
application number: ANDA080157
ndc (product): 70954-484
PYRAZINAMIDEPYRAZINAMIDE TABLETMARLEX PHARMACEUTICALS, INCdb250a85-2e20-87e9-e053-2a95a90a72b62025-12-04Warnings, Adverse reactionsExact identifier
application applno (ANDA): 080157
application number: ANDA080157
PyrazinamidePYRAZINAMIDEAmerican Health Packaginge2dbbdf9-ddfd-4d6d-ad42-6e658969f11e2025-11-13Warnings, Adverse reactionsExact identifier
application applno (ANDA): 080157
application number: ANDA080157

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
198181pyrazinamide 500 MG Oral TabletPSNdb250a85-2e20-87e9-e053-2a95a90a72b65
198181pyrazinamide 500 MG Oral TabletSCDdb250a85-2e20-87e9-e053-2a95a90a72b65
198181PZA 500 MG Oral TabletSYdb250a85-2e20-87e9-e053-2a95a90a72b65
198181pyrazinamide 500 MG Oral TabletPSN262d8829-728c-48db-b89b-88d13b87e6842
198181pyrazinamide 500 MG Oral TabletPSNe2dbbdf9-ddfd-4d6d-ad42-6e658969f11e2
198181pyrazinamide 500 MG Oral TabletSCD262d8829-728c-48db-b89b-88d13b87e6842
198181pyrazinamide 500 MG Oral TabletSCDe2dbbdf9-ddfd-4d6d-ad42-6e658969f11e2
198181PZA 500 MG Oral TabletSY262d8829-728c-48db-b89b-88d13b87e6842
198181PZA 500 MG Oral TabletSYe2dbbdf9-ddfd-4d6d-ad42-6e658969f11e2

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startMarketing endSampleExclude flagStatus
70954-484-107095404841060 TABLET in 1 BOTTLE (70954-484-10) 60 tablet2021-05-110000-00-00NoNoCurrent
70954-484-207095404842090 TABLET in 1 BOTTLE (70954-484-20) 90 tablet2021-05-110000-00-00NoNoCurrent
70954-484-3070954048430100 TABLET in 1 BOTTLE (70954-484-30) 100 tablet2021-05-110000-00-00NoNoCurrent
70954-484-4070954048440500 TABLET in 1 BOTTLE (70954-484-40) 500 tablet2021-05-110000-00-00NoNoCurrent